Embibatinib
Embibatinib (TERN-701) is an orally active and allosteric BCR-ABL1 tyrosine kinase inhibitor targeting the myristoyl pocket. Embibatinib exhibits an IC50 of 0.38 nM against ABL1 wild-type enzyme. Embibatinib can be used for the study of chronic myeloid leukemia (CML).
For research use only. We do not sell to patients.
- CAS No.: 2412966-86-8
- Formula: C23H18ClF4N5O3
- Molecular Weight:523.87
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
Abl1 0.38 nM (IC50) |
Embibatinib (TERN-701, compound 1) demonstrates potent ABL1 inhibitory activity with an IC50 of 0.38 nM[1].
Embibatinib shows great potency against several BCR-ABL1 resistance mutations. The total IC90 values in KCL22 cell lines are 15.3 ng/mL (sensitive) and 72.2 ng/mL (least sensitive non-T315I)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2412966-86-8
-
Molecular Weight 523.87
-
Formula C23H18ClF4N5O3
-
SMILES
OC[C@H](N1C2=C(C3=CN=CN=C3)C=C(C=C2N=C1C(F)F)C(NC4=CC=C(C=C4)OC(F)(F)Cl)=O)C
-
Synonyms
TERN-701
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Embibatinib Related Classifications
HY-182792 Related Classifications
Powered by Bioz